Trial
NCT04252430
RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
MedDay Pharmaceuticals SA
Collaborators
Eurofins Optimed
Condition
Healthy Volunteers
Intervention
MD1003
Why stopped
Due to other phase 3 trial failure to meet primary endpoint
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-05-13